First Trust NYSE Arca Biotechnology Index Fund Rating → Do This Today BEFORE Biden Wins in November (From Stansberry Research) (Ad) Free FBT Stock Alerts $148.98 +0.21 (+0.14%) (As of 04:10 PM ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings First Trust NYSE Arca Biotechnology Index Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FBT Aggregate RatingModerate Buy2.61Holdings in FBT have an aggregate rating of Moderate Buy based on 427 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).FBT Aggregate Price Target$195.7031.05% UpsideHigh Prediction$263.21Average Prediction$195.70Low Prediction$142.55Holdings in FBT have an aggregate price target of $195.70 and a range of $142.55 to $263.21 covering 30 companies (99.9% of the portfolio).FBT Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by First Trust NYSE Arca Biotechnology Index Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 FBT Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.96%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Analyst Forecast3.81%BGNEBeiGene$161.13-4.5%3 of 5 stars2.80$251.93 56.4%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.68%UTHRUnited Therapeutics$264.27-0.7%5 of 5 stars2.90$308.78 16.8%10Insider Selling3.58%BIIBBiogen$221.50-0.6%5 of 5 stars2.65$290.92 31.3%26Positive News3.54%BNTXBioNTech$91.67-0.4%3 of 5 stars2.27$118.82 29.6%11Analyst ForecastShort Interest ↑Analyst Revision3.54%CORTCorcept Therapeutics$27.04+1.7%5 of 5 stars3.00$40.10 48.3%4Short Interest ↓3.54%ITCIIntra-Cellular Therapies$64.96-0.9%5 of 5 stars2.90$90.17 38.8%10Earnings ReportAnalyst ForecastAnalyst Revision3.46%AMGNAmgen$310.15-0.9%5 of 5 stars2.52$305.65 -1.5%21Analyst Forecast3.45%ARGXargenx$374.63-2.1%3 of 5 stars2.71$528.16 41.0%21Earnings ReportAnalyst ForecastShort Interest ↑News Coverage3.45%NBIXNeurocrine Biosciences$136.70-2.1%5 of 5 stars2.74$147.88 8.2%233.44%REGNRegeneron Pharmaceuticals$973.80+0.6%4 of 5 stars2.70$981.71 0.8%203.42%HALOHalozyme Therapeutics$43.15-1.6%5 of 5 stars2.83$53.14 23.2%6Analyst Forecast3.36%ALNYAlnylam Pharmaceuticals$150.47-0.6%5 of 5 stars2.59$216.19 43.7%17Analyst ForecastShort Interest ↑Analyst Revision3.35%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast3.31%ACADACADIA Pharmaceuticals$15.25+0.3%4 of 5 stars2.80$29.38 92.6%16Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews Coverage3.29%MTDMettler-Toledo International$1,510.25+17.0%4 of 5 stars2.17$1,191.57 -21.1%6Earnings ReportNews CoverageGap UpHigh Trading Volume3.29%NTRANatera$105.29+10.2%1 of 5 stars3.00$87.86 -16.6%15Earnings ReportAnalyst DowngradeGap UpHigh Trading Volume3.28%CPRXCatalyst Pharmaceuticals$15.94+1.9%5 of 5 stars3.00$26.43 65.8%5Analyst ForecastShort Interest ↑3.27%INCYIncyte$53.06-0.8%5 of 5 stars2.47$74.93 41.2%17Short Interest ↑3.25%WATWaters$351.11+4.4%3 of 5 stars1.90$305.78 -12.9%10Earnings ReportAnalyst ForecastAnalyst Revision3.24%ILMNIllumina$110.53-0.7%5 of 5 stars2.30$164.65 49.0%20Analyst ForecastShort Interest ↓3.24%ALKSAlkermes$24.05-0.9%5 of 5 stars2.50$35.38 47.1%10Positive News3.22%EXELExelixis$21.37-1.8%5 of 5 stars2.63$26.33 23.2%16Short Interest ↑3.22%RGENRepligen$166.81+1.2%4 of 5 stars2.89$197.75 18.5%93.19%GILDGilead Sciences$65.96+2.1%5 of 5 stars2.39$83.69 26.9%183.14%GMABGenmab A/S$28.84+0.1%3 of 5 stars2.38$48.50 68.2%13Gap Down3.02%BMRNBioMarin Pharmaceutical$81.03-0.8%5 of 5 stars2.63$107.50 32.7%19Short Interest ↑2.91%BEAMBeam Therapeutics$21.26-5.7%2 of 5 stars2.38$40.18 89.0%13Earnings ReportAnalyst ForecastShort Interest ↑Analyst Revision2.82%EXASExact Sciences$53.51-1.2%5 of 5 stars2.92$95.40 78.3%13Analyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume2.66%BRKRBruker$75.71-0.7%5 of 5 stars2.43$84.86 12.1%7 This page (NYSEARCA:FBT) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
